Chromatin structure was altered in MDA-MB-468 and 231-H2N human breast cancer cells by suberoylanilide hydroxamic acid (SAHA), 5-aza-2-deoxycytidine, or hypertonic treatment. The extent and duration of chromatin structural changes were evaluated using the micrococcal nuclease assay. DNA damage (纬H2AX assay) and clonogenic survival were evaluated after exposure to 111In-DTPA-hEGF, an Auger electron-emitting radiopharmaceutical, or IR. The intracellular distribution of 111In-DTPA-hEGF after chromatin modification was investigated in cell fractionation experiments.
Chromatin remained condensed for up to 20 minutes after NaCl and in a relaxed state 24 hours after SAHA treatment. The number of 纬H2AX foci per cell was greater in MDA-MB-468 and 231-H2N cells after IR (0.5 Gy) plus SAHA (1 渭M) compared with IR alone (16 卤 0.6 and 14 卤 0.3 vs. 12 卤 0.4 and 11 卤 0.2, respectively). More 纬H2AX foci were observed in MDA-MB-468 and 231-H2N cells exposed to 111In-DTPA-hEGF (6 MBq/渭g) plus SAHA vs. 111In-DTPA-hEGF alone (11 卤 0.3 and 12 卤 0.7 vs. 9 卤 0.4 and 7 卤 0.3, respectively). 5-aza-2-deoxycytidine enhanced the DNA damage caused by IR and 111In-DTPA-hEGF. Clonogenic survival was reduced in MDA-MB-468 and 231-H2N cells after IR (6 Gy) plus SAHA (1 渭M) vs. IR alone (0.6%卤 0.01 and 0.3%卤 0.2 vs. 5.8%卤 0.2 and 2%卤 0.1, respectively) and after 111In-DTPA-hEGF plus SAHA compared to 111In-DTPA-hEGF alone (21%卤 0.4%and 19%卤 4.6 vs. 33%卤 2.3 and 32%卤 3.7). SAHA did not affect 111In-DTPA-hEGF nuclear localization. Hypertonic treatment resulted in fewer 纬H2AX foci per cell after IR and 111In-DTPA-hEGF compared to controls but did not significantly alter clonogenic survival.
Chromatin structure affects DNA damage and cell survival after exposure to Auger electron radiation.